A Phase 2A randomized, double-blind, placebo-controlled pilot trial of GM604 in patients with Amyotrophic Lateral Sclerosis (ALS Protocol GALS-001) and a single compassionate patie...

por Kindy, Mark, Lupinacci, Paul, Chau, Raymond, Shum, Tony, Ko, Dorothy
Publicado 2017

GM604 regulates developmental neurogenesis pathways and the expression of genes associated with amyotrophic lateral sclerosis

por Swindell, William R., Bojanowski, Krzysztof, Kindy, Mark S., Chau, Raymond M. W., Ko, Dorothy
Publicado 2018

Correction: GM604 regulates developmental neurogenesis pathways and the expression of genes associated with amyotrophic lateral sclerosis

por Swindell, William R., Bojanowski, Krzysztof, Kindy, Mark S., Chau, Raymond M. W., Ko, Dorothy
Publicado 2020